Erschienen in:
26.05.2023 | Image of the Month
Not all black colons on [18F]FDG PET are due to metformin
verfasst von:
Lennert Boeckxstaens, Vibeke Vergote, Daan Dierickx, Thomas Tousseyn, Didier Bielen, Koen Van Laere, Christophe M. Deroose, Karolien Goffin
Erschienen in:
European Journal of Nuclear Medicine and Molecular Imaging
|
Ausgabe 11/2023
Einloggen, um Zugang zu erhalten
Excerpt
Antidiabetic treatment with metformin is known to induce changes in glucose uptake in normal organs [
1]. Metformin treatment increases [
18F]FDG-uptake in the bowel with typically intense and diffuse uptake along the bowel, strongly predominant in the colon [
2]. We here report a case with a similar pattern of intense and diffuse [
18F]FDG-uptake along the colon of a 58-year-old patient experiencing rectal bleeding and diarrhea with a medical history of lung transplantation due to end-stage interstitial lung disease. Simultaneously acquired CT images of the [
18F]FDG PET/CT demonstrate wall thickening of the entire colon with mild infiltration of the paracolic fat tissue and some prominent mesenterial lymph nodes. [
18F]FDG PET/CT also demonstrates a liver lesion cranially in the liver and multiple lymph nodes with high [
18F]FDG-uptake. Given the highly elevated EBV PCR titers (6758 IU/ml) the lesions were strongly suspicious of posttransplant lymphoproliferative disease (PTLD). A colonoscopy was performed to exclude PTLD in the colon and showed severe colitis with ulcerations of which anatomopathological analysis confirmed PTLD. Diffuse and intense [
18F]FDG-uptake in the bowel is also observed in other cases of graft-versus-host disease and inflammatory bowel disease [
3,
4]. Intense [
18F]FDG-uptake in the bowel is not always induced by metformin treatment and further examination can be required, especially when gastrointestinal symptoms are present. …